| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 45 |
|
Cost of Revenue
|
-- | -- | -- | 0 | -14 |
|
Gross Profit
|
-- | -- | -- | 0 | 31 |
| Selling, General and Administrative Expenses
|
-7,987 | -10,503 | -12,898 | -15,984 | -15,902 |
|
Research and Development Expenses
|
-9,864 | -9,737 | -8,878 | -13,008 | -7,257 |
| Other Income/Expense, Operating
|
0 | 50 | 181 | 2,885 | 0 |
|
Operating Income/Expenses
|
-17,851 | -20,190 | -21,595 | -26,107 | -23,159 |
|
Total Operating Profit/Loss
|
-17,851 | -20,190 | -21,595 | -26,107 | -23,128 |
| Total Net Finance Income/Expense
|
-156 | -207 | -933 | -3,749 | -158 |
| Net Investment Income
|
33 | 2 | 324 | 1,178 | -2,125 |
| Irregular Income/Expenses
|
244 | 244 | 0 | -471 | 0 |
|
Other Income/Expense, Non-Operating
|
239 | 103 | 9 | -51 | -5 |
|
Non-Operating Income/Expenses, Total
|
360 | 142 | -600 | -3,093 | -2,288 |
|
Pretax Income
|
-17,491 | -20,048 | -22,195 | -29,200 | -25,416 |
|
Provision for Income Tax
|
-17 | -15 | -14 | -16 | -11 |
|
Net Income from Continuing Operations
|
-17,508 | -20,063 | -22,209 | -29,216 | -25,427 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-17,508 | -20,063 | -22,209 | -29,216 | -25,427 |
|
Non-Controlling/Minority Interests
|
35 | 157 | 66 | 0 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-17,473 | -19,906 | -22,143 | -29,216 | -25,427 |
| Preferred/Other Stock Distribution
|
-5,982 | -5,673 | -1,671 | 0 | -- |
|
Net Income Available to Common Stockholders
|
-23,455 | -25,579 | -23,814 | -29,216 | -25,427 |
|
Diluted Net Income Available to Common Stockholders
|
-23,455 | -25,579 | -23,814 | -29,216 | -25,427 |
| Basic EPS
|
-36.47 | -95.20 | -571.20 | -3.33k | -1.36k |
| Diluted EPS
|
-36.47 | -95.20 | -571.20 | -3.33k | -1.36k |
|
Basic Weighted Average Shares Outstanding
|
704.3750 | 268.8750 | 41.6880 | 8.7810 | 18.7010 |
|
Diluted Weighted Average Shares Outstanding
|
704.3750 | 268.8750 | 41.6880 | 8.7810 | 18.7010 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-17,335 | -19,841 | -21,262 | -28,131 | -25,258 |
|
EBITDA
|
-15,621 | -18,190 | -19,727 | -26,875 | -25,005 |
|
Normalized EBITDA
|
-14,531 | -16,328 | -17,094 | -22,768 | -16,737 |
12/31/2022 - 11/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade